Director, Payer Strategy, Marketing and Policy

Company Overview

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease.

At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more , and follow us on X, Linked In and Facebook.

The Director of Payer Marketing, Strategy and Policy brings extensive Market Access strategic experience to Dyne’s first product launches in neuromuscular disease, with an initial focus on launch readiness and commercialization of our lead assets in Duchenne Muscular Dystrophy (DMD) and myotonic dystrophy Type I (DM1). The Director develops and implements Access strategies and tactics across Payer, Field Reimbursement, and Patient Support Services.

They collaborate with Legal, Compliance, Marketing, Sales, Market Access, Patient Services, Commercial Operations, and other stakeholders as necessary.

This position ensures Dyne has the most efficient and seamless way possible of reaching HCPs, patients, payers, and other key stakeholders living with these severe diseases. Additionally, the Director supports understanding policy at the state Medicaid and federal level that impacts access to products and works with outside partners to enable a seamless and impactful action plan to influence change.

A successful candidate is a self-starter who is highly driven, collaborative, and embodies values such as bold thinking, agility, and a focus on execution. This is a unique opportunity for an exceptional strategic thinker and commercial leader to play a key role in bringing critical therapies to the patients who need them.

This role is based in Waltham, MA.

• Support development of Payer Value Propositions and associated resources. Craft compelling, evidence-based value propositions tailored to payers (commercial, Medicare, Medicaid). Align messaging with product clinical, economic, and humanistic value.
• Create Access Marketing Tools & Resources. Develop payer-facing materials such unmet need, PIE decks, value decks and objection handlers while informing AMCP dossier and HEOR material development. Ensure materials are compliant with regulatory and legal standards.
• Market Access Strategy Development. Collaborate with cross-functional teams (e.g., HEOR, Pricing, Medical Affairs, Sales) to build payer strategy across product lifecycle.
• Support Pricing & Contracting Strategy. Provide US payer perspective to guide contract pull-through strategies.
• Payer & Stakeholder Engagement. Support Account Directors and Field Access teams with payer engagement initiatives.
• Develop customized tools and communication strategies for key stakeholders (e.g., payers, IDNs, ACOs).
• Partner with Patient Support, Marketing, Commercial Analytics and Sales to continually monitor, assess and evolve the distribution strategy and tactics to ensure objectives are met and exceeded.
• Develop HCP and patient-facing resources in support of Patient Support Services and Distribution, inclusive of services across Hub, Financial Assistance, and accessing product.
• Training & Enablement. Train Market Access and Sales teams on payer messaging, tools, and tactics. Create and maintain access marketing training content.
• Develop and execute on a strategic plan for state level policy engagement to overcome any patient access hurdles that may impact patient’s ability to access product in FFS Medicaid. Work with outside partners to stay abreast of state issues and programs that impact patient access.

• BA/BS degree required; advanced degree (MBA, PhD, Pharm
  
  D) preferred.
• 10+ years of bio/pharmaceutical experience required with a key understanding of current US pharmaceutical payer, patient support, and distribution processes.
• Previous rare disease experience and…